Lipella Pharmaceuticals Inc. (LIPO) — DEF 14A Filings
All DEF 14A filings from Lipella Pharmaceuticals Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Lipella Pharma Files Definitive Proxy Statement
— Nov 12, 2024 Risk: low
Lipella Pharmaceuticals Inc. filed its Definitive Proxy Statement (DEF 14A) on November 12, 2024, for the fiscal year ending December 31, 2024. The filing conce -
Lipella Pharmaceuticals Files Proxy Statement for Annual Meeting
— Aug 12, 2024 Risk: medium
Lipella Pharmaceuticals Inc. filed a definitive proxy statement (DEF 14A) on August 12, 2024, for its annual meeting on September 10, 2024. The filing concerns
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX